TABLE 2.
Time to Failure or Censoring Event After Treatment (Days Between Treatment Date and When Failure or Censor Events Occurred)
| Mean (SD) | Median | Minimum-Maximum | Q1-Q3 | P | |
|---|---|---|---|---|---|
| For all eyes | |||||
| Overall | 410.50 (346.62) | 301 | 56-2371 | 181-516 | |
| IOP categories | <0.0001* | ||||
| For baseline IOP <18 mmH g | 323.80 (250.91) | 256 | 56-2300 | 168-385 | |
| For baseline IOP 18-24 mm Hg | 412.08 (338.72) | 309 | 56-2371 | 186-520 | |
| For baseline IOP>24 mm Hg | 480.41 (410.38) | 349 | 56-2360 | 182-644 | |
| Glaucoma categories | |||||
| Glaucoma suspect | 464.47 (391.58) | 332 | 56-2371 | 189-608 | |
| POAG | 388.88 (321.21) | 294 | 56-2360 | 178-488 | |
| Trauma | 416.63 (380.65) | 279 | 56-2070 | 149-552 | |
| Inflammation/drugs | 379.78 (352.02) | 260 | 57-2220 | 158-476 | |
| Other glaucoma | 390.20 (356.65) | 263.5 | 57-2321 | 175-447.5 | |
| Unspecified glaucoma | 471.58 (415.76) | 320 | 56-2334 | 188-609 | |
| Angle recession status | |||||
| No | 410.53 (346.63) | 301 | 56-2371 | 181-516 | |
| Yes | 362.26 (328.79) | 287.5 | 62-1932 | 153-428 | |
| Uveitis status | |||||
| No | 411.08 (347.07) | 302 | 56-2371 | 181-517 | |
| Yes | 327.44 (261.10) | 254 | 57-1932 | 144-406 | |
| For eyes in the analysis that reached fail event | |||||
| Overall | 574.85 (453.85) | 441 | 56-2371 | 248-782 | |
| IOP categories | <0.0001* | ||||
| For baseline IOP <18 mm Hg | 431.79 (360.93) | 331 | 56-2300 | 163-567 | |
| For baseline IOP 18-24 mm Hg | 563.23 (441.94) | 433 | 56-2371 | 248-758 | |
| For baseline IOP>24 mm Hg | 650.35 (488.54) | 511 | 56-2360 | 291-901 | |
| Glaucoma categories | |||||
| Glaucoma suspect | 675.27 (501.94) | 533 | 56-2371 | 279-1008 | |
| POAG | 527.15 (414.69) | 414 | 56-2360 | 238-699 | |
| Trauma | 633.21 (492.04) | 522 | 56-2070 | 215-896 | |
| Inflammation/drugs | 643.95 (466.90) | 518 | 71-2220 | 324-871 | |
| Other glaucoma | 603.64 (528.48) | 352 | 57-2321 | 251-830 | |
| Unspecified glaucoma | 835.20 (599.96) | 744 | 56-2334 | 275-1296 | |
| Angle recession status | |||||
| No | 574.99 (453.84) | 441 | 56-2371 | 248-782 | |
| Yes | 411.76 (451.93) | 322 | 66-1932 | 171-390 | |
| Uveitis status | |||||
| No | 575.58 (454.66) | 441 | 56-2371 | 248-783 | |
| Yes | 489.35 (336.88) | 385.5 | 60-1932 | 244-703 | |
| For eyes in the analysis that did not reach failure event | |||||
| Overall | 353.52 (278.88) | 273 | 57-2340 | 173-434 | |
| IOP categories | <0.0001* | ||||
| For baseline IOP <18 mm Hg | 302.42 (216.49) | 248 | 57-1943 | 168-357 | |
| For baseline IOP 18-24 mm Hg | 360.98 (277.77) | 281 | 57-2296 | 180-446 | |
| For baseline IOP>24 mm Hg | 390.86 (328.88) | 290 | 57-2340 | 160-508 | |
| Glaucoma categories | |||||
| Glaucoma suspect | 385.09 (305.26) | 293 | 57-2227 | 179-490 | |
| POAG | 339.53 (263.39) | 266 | 57-2340 | 170-414 | |
| Trauma | 328.51 (281.24) | 245.5 | 58-1840 | 133-409 | |
| Inflammation/drugs | 272.11 (214.96) | 208 | 57-1185 | 125-341 | |
| Other glaucoma | 327.62 (258.80) | 252 | 57-1604 | 168-385 | |
| Unspecified glaucoma | 401.37 (326.08) | 297 | 57-2212 | 183-510 | |
| Angle recession status | |||||
| No | 353.53 (278.90) | 273 | 57-2340 | 173-434 | |
| Yes | 333.24 (233.82) | 259 | 62-959 | 153-428 | |
| Uveitis status | |||||
| No | 354.17 (279.32) | 273 | 57-2340 | 173-434 | |
| Yes | 254.16 (174.99) | 208 | 57-992 | 126-329 | |
*
Statistically significant.
All P values are from analysis of variance.
IOP indicates intraocular pressure; POAG, primary open angle glaucoma; Q1-Q3, first and third quartiles.